Mouse monoclonal [KT98] Anti-Rat IgG2b H&L (HRP) (ab106750)
Key features and details
- Mouse monoclonal [KT98] Anti-Rat IgG2b H&L (HRP)
- Conjugation: HRP
- Host species: Mouse
- Isotype: IgG1
- Suitable for: WB, ELISA
Overview
-
Product name
Mouse monoclonal [KT98] Anti-Rat IgG2b H&L (HRP)
See all IgG2b secondary antibodies -
Host species
Mouse -
Target species
Rat -
Specificity
ab106750 does not cross-react with Rat IgG1, IgG2a, IgG2c and IgM. -
Tested applications
Suitable for: WB, ELISAmore details -
Immunogen
Rat IgG2b
-
Conjugation
HRP
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
Preservative: 0.01% Thimerosal (merthiolate)
Constituent: PBS -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
KT98 -
Isotype
IgG1 -
Research areas
Associated products
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab106750 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB |
1/1000.
|
|
ELISA |
1/3000.
|
Notes |
---|
WB
1/1000. |
ELISA
1/3000. |
Images
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (2)
ab106750 has been referenced in 2 publications.
- Esteve D et al. Adult Neural Stem Cell Migration Is Impaired in a Mouse Model of Alzheimer's Disease. Mol Neurobiol 59:1168-1182 (2022). PubMed: 34894324
- Hayashi H et al. Preclinical study of a DNA vaccine targeting SARS-CoV-2. Curr Res Transl Med 70:103348 (2022). PubMed: 35489099